WallStSmart

ICL Israel Chemicals Ltd (ICL)vsNutrien Ltd (NTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nutrien Ltd generates 254% more annual revenue ($27.29B vs $7.71B). NTR leads profitability with a 8.7% profit margin vs 4.0%. NTR appears more attractively valued with a PEG of 1.98. ICL earns a higher WallStSmart Score of 59/100 (C).

ICL

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 5.0Value: 4.7Quality: 6.0
Piotroski: 2/9Altman Z: 2.13

NTR

Buy

57

out of 100

Grade: C

Growth: 3.3Profit: 6.5Value: 4.7Quality: 6.5
Piotroski: 6/9Altman Z: 1.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ICLUndervalued (+0.5%)

Margin of Safety

+0.5%

Fair Value

$5.78

Current Price

$5.36

$0.42 discount

UndervaluedFair: $5.78Overvalued
NTRSignificantly Overvalued (-29.7%)

Margin of Safety

-29.7%

Fair Value

$56.34

Current Price

$77.09

$20.75 premium

UndervaluedFair: $56.34Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ICL3 strengths · Avg: 9.3/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

EPS GrowthGrowth
51.6%10/10

Earnings expanding 51.6% YoY

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

NTR3 strengths · Avg: 8.7/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

P/E RatioValuation
16.0x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$1.99B8/10

Generating 2.0B in free cash flow

Areas to Watch

ICL4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.3%3/10

ROE of 4.3% — below average capital efficiency

Profit MarginProfitability
4.0%3/10

4.0% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
9.442/10

Expensive relative to growth rate

NTR4 concerns · Avg: 4.0/10
PEG RatioValuation
1.984/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.0%4/10

4.0% revenue growth

EPS GrowthGrowth
1.2%4/10

1.2% earnings growth

Altman Z-ScoreHealth
1.734/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ICL

The strongest argument for ICL centers on Price/Book, EPS Growth, Revenue Growth. Revenue growth of 16.5% demonstrates continued momentum.

Bull Case : NTR

The strongest argument for NTR centers on Price/Book, P/E Ratio, Free Cash Flow.

Bear Case : ICL

The primary concerns for ICL are Return on Equity, Profit Margin, Piotroski F-Score. Thin 4.0% margins leave little buffer for downturns.

Bear Case : NTR

The primary concerns for NTR are PEG Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

ICL profiles as a growth stock while NTR is a value play — different risk/reward profiles.

NTR carries more volatility with a beta of 1.08 — expect wider price swings.

ICL is growing revenue faster at 16.5% — sustainability is the question.

NTR generates stronger free cash flow (2.0B), providing more financial flexibility.

Bottom Line

ICL scores higher overall (59/100 vs 57/100) and 16.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ICL Israel Chemicals Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

ICL Group Ltd, is a company specialized in minerals and chemical products worldwide. The company is headquartered in Tel Aviv, Israel.

Visit Website →

Nutrien Ltd

BASIC MATERIALS · AGRICULTURAL INPUTS · USA

Nutrien Ltd. provides inputs, services and solutions for crops. The company is headquartered in Saskatoon, Canada.

Visit Website →

Want to dig deeper into these stocks?